IgE-binding peptides coupled to a commercial matrix as a diagnostic instrument for persistent cow's milk allergy - 18/08/11
Doi : 10.1016/j.jaci.2005.05.007
Kirsten Beyer, MD a, b, Kirsi-Marjut Jarvinen, MD, PhD a, Ludmilla Bardina, MS a, Michelle Mishoe a, Kristiina Turjanmaa, MD c, Bodo Niggemann, MD b, Staffan Ahlstedt, PhD d, e, Lennart Venemalm, PhD e, Hugh A. Sampson, MD a
a Mount Sinai School of Medicine, New York, NY
b Department of Pediatric Pneumology and Immunology, University Children's Hospital Charité, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany
c Tampere University Hospital, Tampere, Finland
d Department of Environmental Medicine and Center for Allergy Research, Karolinska Institute, Stockholm, Sweden
e Pharmacia Diagnostics AB, Uppsala, Sweden
Le texte complet de cet article est disponible en PDF.
| Supported by a grant from the National Institutes of Health (AI-44236). Disclosure of potential conflict of interest: K. Beyer has received grants/research support from Danone. S. Ahlstedt and L. Venemalm are employed by Pharmacia Diagnostics. H. Sampson has a consultant arrangement with Seer, Inc, and has received grants/research support from the National Institutes of Health and Pharmacia Diagnostics (through Mount Sinai School of Medicine). |
© 2005
American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 116 - N° 3
P. 704-705 - septembre 2005 Retour au numéro
Article précédent
- Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection
- Howard M. Rosenblatt, Lin Y. Song, Sharon A. Nachman, Kenneth E. Stanley, Paul A. Krogstad, George M. Johnson, Andrew A. Wiznia, the Pediatric AIDS Clinical Trials Group 377 Study Team ∗ Houston, Tex, Boston, Mass, Stony Brook and Bronx, NY, Los Angeles, Calif, and Charleston, SC
- Topical viscous budesonide suspension for treatment of eosinophilic esophagitis
- Seema S. Aceves, Ranjan Dohil, Robert O. Newbury, John F. Bastian
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?